The Clone Ranger?
Open Access
- 1 September 2008
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (9) , 1520-1521
- https://doi.org/10.1038/mt.2008.154
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsBlood, 2008
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1New England Journal of Medicine, 2008
- Cancer Immunotherapy — The Endgame BeginsNew England Journal of Medicine, 2008
- Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferBlood, 2007
- Translating Innate Immunity into Immunological Memory: Implications for Vaccine DevelopmentPublished by Elsevier ,2006
- Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytesBlood, 2005
- Adoptive T cell therapy using antigen-specific CD8+T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cellsProceedings of the National Academy of Sciences, 2002
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLsBlood, 2001
- Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant RecipientsBlood, 1998